1-3 of 3
Christian Unzicker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Lenalidomide Maintenance to Prevent Relapse of High-Risk MDS and AML Patients with Del(5q) Following Allogeneic HCT - Results of the “LENAMAINT” Trial

Katja Sockel, MD, Jochen Greiner, MD, Rudolf Trenschel, MD, Christian Unzicker, MD, Guido Kobbe, MD, Jürgen Finke, MD, Ulrich Germing, MD, Brigitte Mohr, Dietrich Beelen, Gerhard Ehninger, MD, Martin Bornhaeuser, Uwe Platzbecker, MD
Journal: Blood
Blood (2011) 118 (21): 3060.
https://doi.org/10.1182/blood.V118.21.3060.3060
Published: 2011
Journal Articles

Mutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survival

Torsten Steinbrunn, Thorsten Stühmer, Stefan Gattenlöhner, Andreas Rosenwald, Anja Mottok, Christian Unzicker, Hermann Einsele, Manik Chatterjee, Ralf C. Bargou
Journal: Blood
Blood (2011) 117 (6): 1998–2004.
https://doi.org/10.1182/blood-2010-05-284422
Published: 2011
Includes: Supplemental data
Journal Articles

Signaling Profile and Anti-Tumor Activity of the Novel HSP90 Inhibitor NVP-AUY922 in Multiple Myeloma.

Thorsten Stühmer, Angela Zöllinger, Daniela Siegmund, Manik Chatterjee, Evelyn Grella, Stefan Knop, Martin Kortüm, Christian Unzicker, Michael R. Jensen, Cornelia Quadt, Patrick Chène, Joseph Schoepfer, Carlos Garcia-Echeverria, Herrmann Einsele, Harald Wajant, Ralf C. Bargou
Journal: Blood
Blood (2007) 110 (11): 4788.
https://doi.org/10.1182/blood.V110.11.4788.4788
Published: 2007